Related Experiment Videos
Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease
Shayla Bergmann1, Deyi Zheng, Julio Barredo
1Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Insights
Urinary kallikrein may indicate progressive kidney damage in children with sickle cell disease (SCD). Higher kallikrein levels correlate with increased albuminuria, suggesting its potential as a risk marker for sickle cell nephropathy (SCN).
Area of Science:
- Nephrology
- Pediatrics
- Hematology
Background:
- Sickle cell disease (SCD) management has improved survival, but end-organ damage, particularly renal failure (affecting 20% of patients), remains a significant concern.
- Sickle cell nephropathy (SCN) involves glomerular changes, albuminuria, and declining kidney function, with underlying mechanisms not fully understood.
- Renal kallikrein's role as a potential risk marker for SCN requires further investigation.
Purpose of the Study:
- To explore the role of renal kallikrein as a risk marker for promoting sickle cell nephropathy (SCN) in children.
- To investigate the correlation between urinary kallikrein excretion and markers of kidney damage in children with SCD.
Main Methods:
- A cross-sectional study measured urinary active kallikrein excretion rates in 73 children with sickle cell anemia (SCD) and 30 healthy controls.
- Statistical analyses, including cross-sectional and multivariate regression, were used to assess correlations between kallikrein, albumin excretion rate (AER), age, and hemoglobin levels.
Main Results:
- A significant positive correlation was found between active kallikrein excretion and albumin excretion rate (AER) in children with SCD (P<0.0088).
- Active kallikrein excretion negatively correlated with hemoglobin levels (P<0.0096), and AER positively correlated with age.
- Multivariate analysis indicated that age (20%) and log kallikrein (6%) significantly influenced AER variability in children with SCD.
Conclusions:
- Urinary active kallikrein is positively and independently correlated with AER in children with SCD.
- Kallikrein may serve as a potential marker for progressive nephropathy in sickle cell disease.
- Longitudinal studies are recommended to confirm these findings and establish kallikrein's role in SCN progression.
Objective:
Although improvements in the management of sickle cell disease (SCD) have increased patient survival into adulthood, morbidity and mortality from end-organ damage remain major concerns. One of the most serious complications of SCD is renal failure, affecting about 20% of patients. The clinical manifestations of sickle cell nephropathy (SCN) involve changes in glomerular ultrastructure, albuminuria, and a progressive decline in glomerular hemodynamics. The mechanisms or factors that promote SCN are not fully elucidated. In the present study, the role of renal kallikrein as a risk marker for promoting SCN was explored in a cross-sectional study.
Methods And Results:
We measured the urinary excretion rate of active kallikrein in 73 children with sickle cell anemia (hemoglobin SS, SC, or S thalassemia) and in 30 control healthy African American children. The findings demonstrated that a significant difference in the excretion rate of log kallikrein in male versus female patients with SCD, P<0.0078 was observed. In children with SCD, cross-sectional analysis revealed a positive and significant correlation between the excretion rate of active kallikrein and log albumin excretion rate (AER), P<0.0088. Regression analysis also determined that the excretion rate of active kallikrein negatively correlates with hemoglobin in children with SCD, P<0.0096. In addition, an inverse relationship between log AER and hemoglobin was observed in male patients with SCD, P<0.0143. In children with SCD, cross-sectional analysis revealed a positive and significant correlation between log AER and age, suggesting age as a risk marker for AER in SCD. In multivariate regression analysis, our findings demonstrate a strong association between log AER and age and log kallikrein in children with SCD. About 20% of the variability in log AER in SCD patients is influenced by age and 6% is influenced by log kallikrein, P<0.0001 and P<0.02, respectively.
Conclusions:
These findings provide the first evidence that the excretion rate of active kallikrein is positively and independently correlated with log AER in children with SCD, and suggest that kallikrein could be a marker for progressive nephropathy. Longitudinal studies are essential to address this issue.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Nephrons
Diabetic Nephropathy
Serum Studies: Renal Function Tests
Acute Kidney Injury III: Clinical Manifestations